Suven Life Sciences Rights Issue will open for subscription from 31 October 2022. The company aims for an issue size of ₹399.80 Crores through this rights issue.
Suven Life Sciences Limited
Incorporated in 1989, Suven Life Sciences provides a wide range of Drug Discovery and Development Support Services (DDDSS) to global Pharma and Biotech companies. Suven discovery research is focused on discovering and developing new chemical entities (NCEs), which are best-in-class central nervous system therapies for the treatment of cognitive disorders, major depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, and gastrointestinal motility disorders.
Suven Life Sciences Rights Issue Timetable
| Record Date | 18 October 2022 |
| Credit of Rights Entitlements | 28 October 2022 |
| Bid/Offer Opens On | 31 October 2022 |
| Renunciation of Rights Entitlements | 03 November 2022 |
| Bid/Offer Closes On | 10 November 2022 |
| Deemed Date of Allotment | 18 November 2022 |
| Credit Date | 21 November 2022 |
| Listing Date | 24 November 2022 |
Rights Issue Details
| Issue Open | Oct 31, 2022 – Nov 10, 2022 |
| Security Name | Suven Life Sciences Limited |
| Issue Size (Shares) | 72,691,239 |
| Issue Size (Amount) | ₹399.80 Crores |
| Issue Price | ₹55 per share |
| Face Value | ₹1 per share |
| Listing At | BSE, NSE |
| Entitlement | 1 Equity Share for every 2 Equity Shares held on the Record Date |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 128.42 | 21.23 | -72.15 |
| 31-Mar-22 | 108.03 | 17.16 | -122 |
Lead Manager(s)
- Ernst & Young Merchant Banking Services LLP
Rights Issue Registrar
- KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: suven.rights@kfintech.com
Website: https://karisma.kfintech.com/
Company Contact Information
Suven Life Sciences Limited
8-2-334, SDE Serene Chambers,
6th Floor Road No.5, Avenue 7, Banjara Hills,
Hyderabad – 500 034
Phone: 91 40 2354 1142
Email: info@suven.com
Website: http://www.suven.com/
Final thoughts
Suven Life Sciences Rights Issue is going to open for subscription soon. applying for rights Issue is purely a personal choice. study well about the company and do subscribe if you are feeling good about the company. I hope this post will give you enough details to make a fundamental study of the company. learn well and make wise decisions.
Happy Investing
